Clinical Trials Directory

Trials / Completed

CompletedNCT07232771

Reinfection and Re-revision Rates of Periprosthetic Knee Infection Under Four Different Surgical Strategies

Reinfection and Re-revision Rates of Periprosthetic Knee Infection Under Four Different Surgical Strategies: a Single Centre Retrospective Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
First Affiliated Hospital of Fujian Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A single-center retrospective cohort study was conducted in the Department of Orthopedics, the First Affiliated Hospital of Fujian Medical University. This study reviewed 145 patients who underwent debridement, antibiotics, and implant retention (DAIR), 1-stage revision, 1.5-stage revision, and 2-stage revision surgeries for total knee arthroplasty periprosthetic joint infection (TKA-PJI) at this institution between 2012 and 2022. The differences in postoperative reinfection rate, microbial composition of reinfection, short-term and long-term aseptic prosthesis survival rate, prosthesis loosening and revision rate due to any cause, and long-term loosening-free survival rate among the four revision surgical approaches for TKA-PJI were evaluated, so as to provide reference value for clinical decision-making.

Detailed description

A single-center retrospective cohort study was conducted in the Department of Orthopedics, the First Affiliated Hospital of Fujian Medical University. This study reviewed 145 patients who underwent debridement, antibiotics, and implant retention (DAIR), 1-stage revision, 1.5-stage revision, and 2-stage revision surgeries for total knee arthroplasty periprosthetic joint infection (TKA-PJI) at this institution between 2012 and 2022. In this study, we aimed to evaluate: (1) the postoperative reinfection rates following four surgical strategies for TKA-PJI; (2) the microbial profile of recurrent infections; (3) short- and long-term infection-free implant survival rates across the four surgical approaches; (4) re-revision rates due to aseptic loosening and long-term aseptic loosening-free implant survival rates; and (5) the reinfection rate in patients with positive cultures at the time of reimplantation. In order to provide reference value for clinical decision-making.

Conditions

Timeline

Start date
2023-01-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2025-11-18
Last updated
2025-11-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07232771. Inclusion in this directory is not an endorsement.